ABY-035 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
271強直性脊椎炎1

271. 強直性脊椎炎


臨床試験数 : 563 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04795141
(ClinicalTrials.gov)
August 24, 20213/3/2021ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisAnkylosing SpondylitisDrug: ABY-035;Drug: Normal salineInmagene BiopharmaceuticalsAffibodyRecruiting18 YearsN/AAll300Phase 2Cayman Islands